{"id":"https://openalex.org/W2472382796","doi":"https://doi.org/10.1182/blood.v114.22.3090.3090","title":"Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.","display_name":"Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.","publication_year":2009,"publication_date":"2009-11-20","ids":{"openalex":"https://openalex.org/W2472382796","doi":"https://doi.org/10.1182/blood.v114.22.3090.3090","mag":"2472382796"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v114.22.3090.3090","doi":"https://doi.org/10.1182/blood.v114.22.3090.3090","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.3090.3090","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049633500","display_name":"Yoshihiro Hatta","orcid":"https://orcid.org/0000-0002-0457-4015","observed_orcids":["https://orcid.org/0000-0002-0457-4015"]},"institutions":[{"id":"https://openalex.org/I104946051","display_name":"Nihon University","ror":"https://ror.org/05jk51a88","country_code":"JP","type":"education","lineage":["https://openalex.org/I104946051"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiro Hatta","raw_affiliation_strings":["Hematology & Rheumatology, Nihon University, Tokyo, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology & Rheumatology, Nihon University, Tokyo, Japan,","institution_ids":["https://openalex.org/I104946051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032219696","display_name":"Shuichi Mizuta","orcid":"https://orcid.org/0000-0001-6690-5409","observed_orcids":["https://orcid.org/0000-0001-6690-5409"]},"institutions":[{"id":"https://openalex.org/I145673806","display_name":"Fujita Health University","ror":"https://ror.org/046f6cx68","country_code":"JP","type":"education","lineage":["https://openalex.org/I145673806"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shuichi Mizuta","raw_affiliation_strings":["Dept. of Hematology, Fujita Health University, Toyoake, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Hematology, Fujita Health University, Toyoake, Japan,","institution_ids":["https://openalex.org/I145673806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013146671","display_name":"Shigeki Ohtake","orcid":"https://orcid.org/0000-0003-0112-6564","observed_orcids":["https://orcid.org/0000-0003-0112-6564"]},"institutions":[{"id":"https://openalex.org/I10091056","display_name":"Kanazawa University","ror":"https://ror.org/02hwp6a56","country_code":"JP","type":"education","lineage":["https://openalex.org/I10091056"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Shigeki Ohtake","raw_affiliation_strings":["Kanazawa University Graduate School of Medical Science, Kanazawa, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanazawa University Graduate School of Medical Science, Kanazawa, Japan,","institution_ids":["https://openalex.org/I10091056"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010994282","display_name":"Isamu Sugiura","orcid":"https://orcid.org/0000-0002-4430-7544","observed_orcids":["https://orcid.org/0000-0002-4430-7544"]},"institutions":[{"id":"https://openalex.org/I4210145862","display_name":"Toyohashi Municipal Hospital","ror":"https://ror.org/03h3tds63","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145862"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Isamu Sugiura","raw_affiliation_strings":["Toyohashi Municipal Hospital, Toyohashi, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Toyohashi Municipal Hospital, Toyohashi, Japan,","institution_ids":["https://openalex.org/I4210145862"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103131907","display_name":"Yasunori Ueda","orcid":"https://orcid.org/0000-0002-4487-5808","observed_orcids":["https://orcid.org/0000-0002-4487-5808"]},"institutions":[{"id":"https://openalex.org/I4210089671","display_name":"Kurashiki Central Hospital","ror":"https://ror.org/00947s692","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210089671"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasunori Ueda","raw_affiliation_strings":["Haematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Haematology/Oncology, Kurashiki Central Hospital, Kurashiki, Japan,","institution_ids":["https://openalex.org/I4210089671"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063503238","display_name":"Heiwa Kanamori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152949","display_name":"Kanagawa Cancer Center","ror":"https://ror.org/00aapa202","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4387152949"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Heiwa Kanamori","raw_affiliation_strings":["Kanagawa Cancer Center, Yokohama, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kanagawa Cancer Center, Yokohama, Japan,","institution_ids":["https://openalex.org/I4387152949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084880219","display_name":"Hideki Akiyama","orcid":"https://orcid.org/0000-0001-5788-8555","observed_orcids":["https://orcid.org/0000-0001-5788-8555"]},"institutions":[{"id":"https://openalex.org/I3020605285","display_name":"Tokyo Metropolitan Komagome Hospital","ror":"https://ror.org/04eqd2f30","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I3020605285"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideki Akiyama","raw_affiliation_strings":["Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan,","institution_ids":["https://openalex.org/I3020605285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101592325","display_name":"Makoto Takeuchi","orcid":"https://orcid.org/0000-0003-0544-712X","observed_orcids":["https://orcid.org/0000-0003-0544-712X","https://orcid.org/0009-0002-2419-5992"]},"institutions":[{"id":"https://openalex.org/I4405282719","display_name":"National Hospital Organization Minami-Okayama Medical Center","ror":"https://ror.org/00c60fh73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210137409","https://openalex.org/I4405282719"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Makoto Takeuchi","raw_affiliation_strings":["National Hospital Organization Minami-Okayama Medical Center, Okayama, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Hospital Organization Minami-Okayama Medical Center, Okayama, Japan,","institution_ids":["https://openalex.org/I4405282719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111484615","display_name":"Noriko Usui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I115498069","display_name":"Jikei University School of Medicine","ror":"https://ror.org/039ygjf22","country_code":"JP","type":"education","lineage":["https://openalex.org/I115498069"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Usui","raw_affiliation_strings":["Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan,","institution_ids":["https://openalex.org/I115498069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085637628","display_name":"Toshiaki Yujiri","orcid":"https://orcid.org/0000-0001-6838-3456","observed_orcids":["https://orcid.org/0000-0001-6838-3456"]},"institutions":[{"id":"https://openalex.org/I173915773","display_name":"Yamaguchi University","ror":"https://ror.org/03cxys317","country_code":"JP","type":"education","lineage":["https://openalex.org/I173915773"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiaki Yujiri","raw_affiliation_strings":["Yamaguchi University School of Medicine, Yamaguchi, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yamaguchi University School of Medicine, Yamaguchi, Japan,","institution_ids":["https://openalex.org/I173915773"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083055988","display_name":"Atsushi Fujieda","orcid":"https://orcid.org/0009-0002-5592-3745","observed_orcids":["https://orcid.org/0009-0002-5592-3745"]},"institutions":[{"id":"https://openalex.org/I178574317","display_name":"Mie University","ror":"https://ror.org/01529vy56","country_code":"JP","type":"education","lineage":["https://openalex.org/I178574317"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Atsushi Fujieda","raw_affiliation_strings":["Mie University Graduate School of Medicine, Tsu, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mie University Graduate School of Medicine, Tsu, Japan,","institution_ids":["https://openalex.org/I178574317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030597247","display_name":"Toru Kiguchi","orcid":"https://orcid.org/0000-0003-2322-4798","observed_orcids":["https://orcid.org/0000-0003-2322-4798"]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Toru Kiguchi","raw_affiliation_strings":["Tokyo Medical University, Tokyo, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tokyo Medical University, Tokyo, Japan,","institution_ids":["https://openalex.org/I158929114"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062828203","display_name":"Itsuro Jinnai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121151","display_name":"Saitama Medical University Hospital","ror":"https://ror.org/02tyjnv32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210121151"]},{"id":"https://openalex.org/I8588240","display_name":"Saitama Medical University","ror":"https://ror.org/04zb31v77","country_code":"JP","type":"education","lineage":["https://openalex.org/I8588240"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Itsuro Jinnai","raw_affiliation_strings":["Department of Hematology, Saitama Medical University Hospital, Saitama, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Saitama Medical University Hospital, Saitama, Japan,","institution_ids":["https://openalex.org/I4210121151","https://openalex.org/I8588240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113454854","display_name":"Tomoki Naoe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I60134161","display_name":"Nagoya University","ror":"https://ror.org/04chrp450","country_code":"JP","type":"education","lineage":["https://openalex.org/I60134161"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoki Naoe","raw_affiliation_strings":["Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan,","institution_ids":["https://openalex.org/I60134161"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110631744","display_name":"Ryuzo Ohno","orcid":"https://orcid.org/0000-0003-2482-5018","observed_orcids":["https://orcid.org/0000-0003-2482-5018"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ryuzo Ohno","raw_affiliation_strings":["Japan Adult Leukemia Study Group, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Adult Leukemia Study Group, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":15,"corresponding_author_ids":["https://openalex.org/A5013146671","https://openalex.org/A5030597247","https://openalex.org/A5083055988","https://openalex.org/A5101592325","https://openalex.org/A5110631744"],"corresponding_institution_ids":["https://openalex.org/I10091056","https://openalex.org/I158929114","https://openalex.org/I178574317","https://openalex.org/I4405282719"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.5284,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.83490415,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"114","issue":"22","first_page":"3090","last_page":"3090"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.989300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-acute-lymphoblastic-leukemia","display_name":"Philadelphia chromosome-positive acute lymphoblastic leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.972000002861023},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8360000252723694},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9750000238418579},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.7260000109672546},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.4059999883174896},{"id":"https://openalex.org/keywords/adult-leukemia","display_name":"adult leukemia","score":0.38499999046325684},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.48399999737739563},{"id":"https://openalex.org/keywords/hla-matched-sibling-donor","display_name":"matched sibling donor","score":0.6669999957084656}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7736610174179077},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.568047285079956},{"id":"https://openalex.org/C2779429289","wikidata":"https://www.wikidata.org/wiki/Q408977","display_name":"Vincristine","level":4,"score":0.5573206543922424},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.534224808216095},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5338807106018066},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5104157328605652},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4950794279575348},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4817959666252136},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.462988018989563},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.46042677760124207},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.43692445755004883},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.4306755065917969},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.41719263792037964},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3960909843444824},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.07014092803001404},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.06486564874649048},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v114.22.3090.3090","doi":"https://doi.org/10.1182/blood.v114.22.3090.3090","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v114.22.3090.3090","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2802056043","https://openalex.org/W2554634465","https://openalex.org/W2554314537","https://openalex.org/W1752976675","https://openalex.org/W2522338288","https://openalex.org/W2593666259","https://openalex.org/W2069526402","https://openalex.org/W107593093","https://openalex.org/W2537976142","https://openalex.org/W3032334791"],"abstract_inverted_index":{"Abstract":[0,1],"3090":[2],"Poster":[3],"Board":[4],"III-27":[5],"The":[6,25,116,241,435,447],"outcome":[7],"of":[8,21,59,62,95,113,127,164,183,216,232,243,273,281,287,303,316,324,345,352,363,378,418,481],"Philadelphia":[9],"chromosome-positive":[10],"acute":[11],"lymphoblastic":[12],"leukemia":[13],"(Ph+ALL)":[14],"has":[15,32],"dramatically":[16],"improved":[17],"since":[18],"the":[19,60,63,68,173,184,217,249,267,274,304,314,329,335,346,376,385,391,439],"start":[20],"treatment":[22],"with":[23,43,84,109,433],"imatinib.":[24,115],"Japan":[26],"Adult":[27],"Leukemia":[28],"Study":[29],"Group":[30],"(JALSG)":[31],"reported":[33],"a":[34,56,138,224,373,450,466],"high":[35],"complete":[36],"remission":[37,70],"(CR)":[38],"rate":[39,247,318,380],"for":[40,121,134,248,319,475],"Ph+ALL":[41,168],"treated":[42],"imatinib-combined":[44,65,440],"chemotherapy":[45,441],"(Yanada":[46],"et":[47],"al,":[48],"J":[49],"Clin":[50],"Oncol":[51],"2006).":[52],"Here":[53],"we":[54],"report":[55],"follow-up":[57,201],"analysis":[58],"results":[61,436],"JALSG":[64],"chemotherapy.":[66],"In":[67,390],"study,":[69],"was":[71,132,146,153,156,186,203,211,229,255,264,294,326,339,388,443],"induced":[72],"by":[73],"administering":[74],"imatinib":[75,131,228],"from":[76,158],"day":[77,80],"8":[78],"to":[79,453,483],"62":[81],"in":[82,172,213,223,226,266,271,285,291,297,300,328,334,341,343,372,384,398,458,469],"combination":[83],"cyclophosphamide,":[85],"daunorubicin,":[86],"vincristine":[87],"(VCR),":[88],"and":[89,102,105,130,155,178,192,197,220,332,357,424,445],"prednisolone":[90],"(PSL).":[91],"Consolidation":[92],"regimen":[93,442,448],"consisted":[94],"an":[96,106,159,459],"odd":[97],"course":[98,108],"comprising":[99],"high-dose":[100,103],"methotrexate":[101],"cytarabine":[104],"even":[107],"28":[110],"days":[111],"administration":[112],"single-agent":[114],"consolidation":[117],"regimens":[118],"were":[119,170,194,235,261,355,430],"alternated":[120],"four":[122],"courses":[123],"each.":[124],"Maintenance":[125],"consisting":[126],"VCR,":[128],"PSL,":[129],"continued":[133],"two":[135,236],"years":[136,188,205,254,280,323,351,383,402],"after":[137],"CR.":[139,374],"Allogeneic":[140],"hematopoietic":[141],"stem":[142],"cell":[143],"transplantation":[144],"(allo-HSCT)":[145],"recommended":[147],"if":[148],"HLA":[149],"identical":[150],"sibling":[151],"donor":[152],"available":[154],"allowed":[157],"alternative":[160],"donor.":[161],"A":[162,209],"total":[163],"103":[165,218],"newly":[166],"diagnosed":[167],"patients":[169,185,219,277,289,306,320,348,365,470],"enrolled":[171],"study":[174],"between":[175],"August":[176,179],"2002":[177],"2004.":[180],"Median":[181,200],"age":[182,325,400],"45":[187],"(range,":[189,206],"15-64":[190],"years),":[191,405],"there":[193],"57":[195],"males":[196],"46":[198],"females.":[199],"period":[202],"2.6":[204],"0.1-5.1":[207],"years).":[208],"CR":[210,269,276],"achieved":[212,222],"100":[214],"(97.1%)":[215],"not":[221,295,395,431,473],"patient":[225],"whom":[227,292],"discontinued":[230],"because":[231],"ileus.":[233],"There":[234],"early":[237],"deaths":[238],"during":[239],"induction.":[240],"probability":[242,315,377],"overall":[244],"survival":[245],"(OS)":[246],"entire":[250],"group":[251,331,387,392],"at":[252,381,428],"three":[253,312,382],"56.8%.":[256],"No":[257,478],"severe":[258],"adverse":[259],"effects":[260],"observed.":[262],"Allo-HSCT":[263,338],"performed":[265,296,340],"1st":[268],"(CR1)":[270],"54":[272,305],"74":[275],"under":[278,321],"55":[279,322,350],"age.":[282,353],"Relapse":[283],"occurred":[284],"18":[286],"20":[288],"(90.0%)":[290],"allo-HSCT":[293,397,455],"CR1,":[298,399],"but":[299],"only":[301],"seven":[302],"(13.0%)":[307],"who":[308,366,471],"underwent":[309,367],"allo-HSCT.":[310,476],"At":[311],"years,":[313],"OS":[317,379],"75.0%":[327],"transplanted":[330],"36.4%":[333],"non-transplanted":[336,386],"group.":[337],"CR1":[342],"eight":[344,364],"25":[347],"over":[349],"Two":[354],"myeloablative":[356],"six":[358],"reduced":[359],"intensity":[360],"conditionings.":[361],"Seven":[362],"HSCT":[368],"are":[369,472],"still":[370,464],"alive":[371],"However,":[375,462],"43.2%.":[389],"that":[393,438],"did":[394],"receive":[396,454],"(55<":[401],"or":[403,415],"55>":[404],"WBC":[406],"count,":[407],"bcr/abl":[408,411],"transcript":[409,412],"level,":[410],"type":[413],"(major":[414],"minor),":[416],"co-expression":[417],"myeloid":[419],"antigens":[420],"(CD13":[421],"and/or":[422],"CD33),":[423],"additional":[425],"chromosomal":[426],"abnormalities":[427],"diagnosis":[429],"associated":[432],"OS.":[434],"demonstrated":[437],"effective":[444],"feasible.":[446],"provided":[449],"better":[451],"chance":[452],"which":[456],"resulted":[457],"excellent":[460],"outcome.":[461],"relapse":[463],"remains":[465],"problem,":[467],"especially":[468],"candidates":[474],"Disclosures":[477],"relevant":[479],"conflicts":[480],"interest":[482],"declare.":[484]},"counts_by_year":[{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-07-22T00:00:00"}